A Study to Evaluate the Long-term Safety and Tolerability of Lu AF20513 and the Antibody Response in Patients With Alzheimer's Disease (AD)
Clinical trial NCT03668405 · TERMINATED
Trial details
- NCT number
- NCT03668405
- Sponsor
- H. Lundbeck A/S
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-26
- Primary completion
- 2019-05-27
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.